Page last updated: 2024-08-21

alpha-aminopyridine and belinostat

alpha-aminopyridine has been researched along with belinostat in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, SS; Dong, M; Feng, FY; Hu, XS; Shi, YK; Xing, PY	1
Devaraj, VC; Mullangi, R; Srinivas, NR; Suresh, PS	1
Ito, Y; Makita, S; Tobinai, K	1
Anglès, F; Balch, WE; Hutt, DM	1

Reviews

3 review(s) available for alpha-aminopyridine and belinostat

Article	Year
[Progress in cancer treatment with histone deacetylase inhibitor]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2013, Volume: 35, Issue:7 Topics: Aminopyridines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Depsipeptides; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Indoles; Neoplasms; Panobinostat; Sulfonamides; Vorinostat	2013
Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine. Biomedical chromatography : BMC, 2017, Volume: 31, Issue:1 Topics: Aminopyridines; Animals; Benzamides; Chromatography, High Pressure Liquid; Depsipeptides; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Neoplasms; Panobinostat; Sulfonamides; Tandem Mass Spectrometry; Vorinostat	2017
Development of new agents for peripheral T-cell lymphoma. Expert opinion on biological therapy, 2019, Volume: 19, Issue:3 Topics: Aminopterin; Aminopyridines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Brentuximab Vedotin; China; Depsipeptides; Drug Approval; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunoconjugates; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Sulfonamides	2019

Other Studies

1 other study(ies) available for alpha-aminopyridine and belinostat

Article	Year
HDAC inhibitors rescue multiple disease-causing CFTR variants. Human molecular genetics, 2019, 06-15, Volume: 28, Issue:12 Topics: Aminopyridines; Benzodioxoles; Cell Membrane; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mutation; Panobinostat; Protein Transport; Sequence Deletion; Sulfonamides	2019

Article

Year

HDAC inhibitors rescue multiple disease-causing CFTR variants.

Human molecular genetics, 2019, 06-15, Volume: 28, Issue:12

Topics: Aminopyridines; Benzodioxoles; Cell Membrane; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mutation; Panobinostat; Protein Transport; Sequence Deletion; Sulfonamides

2019